Souto Selma B, Baptista Pedro V, Barreto Filomena, Sousa Pedro F, Braga Daniel C, Carvalho Davide
School of Medicine, University of Porto, Porto, Portugal.
Arq Bras Endocrinol Metabol. 2012 Dec;56(9):672-6. doi: 10.1590/s0004-27302012000900012.
Virilising ovarian tumours are a rare cause of hyperandrogenism in women, accounting for less than 5% of all ovarian neoplasms. It occurs most often in - and postmenopausal women. We report a case of a 64 year-old woman with signs of virilisation that had started 3 years before. Blood hormone analysis revealed increased levels of testosterone, and 17-hydroxyprogesterone. The tetracosactin test revealed 21-hydroxylase deficiency. Radiological imaging demonstrated a nodule in her left ovary. The patient was submitted to bilateral laparoscopic oophorectomy, and histopathological examination revealed a luteoma of the left ovary. Postoperative serum testosterone level and 17-hydroxyprogesterone returned to normal levels in one month. Virilism regressed within six months. Our patient also showed an elevation in 17-OHP serum levels. Normalization of 17-OHP after oophorectomy suggests a case of intratumoral 21-hydroxylase deficiency. To our knowledge, this is the first description of ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal woman.
男性化卵巢肿瘤是女性雄激素过多症的罕见病因,占所有卵巢肿瘤的比例不到5%。它最常发生于绝经后女性。我们报告一例64岁女性病例,其男性化体征始于3年前。血液激素分析显示睾酮和17-羟孕酮水平升高。四氢皮质醇试验显示21-羟化酶缺乏。影像学检查显示其左卵巢有一个结节。患者接受了双侧腹腔镜卵巢切除术,组织病理学检查显示左卵巢有一个黄体瘤。术后1个月血清睾酮水平和17-羟孕酮恢复正常。男性化体征在6个月内消退。我们的患者还表现出血清17-OHP水平升高。卵巢切除术后17-OHP恢复正常提示为肿瘤内21-羟化酶缺乏病例。据我们所知,这是绝经后女性卵巢肿瘤内21-羟化酶缺乏的首次描述。